<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03735108</url>
  </required_header>
  <id_info>
    <org_study_id>ShanghaiFMIH Shihua Bao</org_study_id>
    <nct_id>NCT03735108</nct_id>
  </id_info>
  <brief_title>Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss</brief_title>
  <official_title>Neutrophil Extracellular Traps Mediate Antiphospholipid Antibody-induced Pregnancy Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai First Maternity and Infant Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai First Maternity and Infant Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Establish a multi-platform detection system for neutrophil extracellular traps in blood
           and tissues, and evaluate the detection performance;

        2. Comparing the expression levels of neutrophil extracellular traps in peripheral blood
           and decidua of patients with antiphospholipid antibody-induced pregnancy loss and normal
           control group;

        3. Comparing the expression levels of neutrophil extracellular traps in peripheral blood
           and decidua of mice with antiphospholipid antibody-induced pregnancy loss and normal
           control group;

        4. After treatment of antiphospholipid antibody-induced mouse abortion model with
           metformin,the effect of metformin on embryo loss rate and viable embryo body weight was
           observed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NETs level</measure>
    <time_frame>through study completion, an average of 8 months</time_frame>
    <description>Neutrophil extracellular traps (NETs) are networks of extracellular fibers, primarily composed of DNA from neutrophils, which bind pathogens.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complete blood count (CBC)</measure>
    <time_frame>through study completion, an average of 8 months</time_frame>
    <description>CBC is a blood panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood, such as the cell count for each blood cell type and the concentrations of hemoglobin.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>C3 level</measure>
    <time_frame>through study completion, an average of 8 months</time_frame>
    <description>Complement component 3, often simply called C3, is a protein of the immune system. It plays a central role in the complement system and contributes to innate immunity.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neutrophil Extracellular Traps; Antiphospholipid Antibody-induced Pregnancy Loss</condition>
  <arm_group>
    <arm_group_label>pregnancy loss group</arm_group_label>
    <description>the times of pregnancy loss more than or equal to twice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal control group</arm_group_label>
    <description>no history of pregnancy loss</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        City
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Recurrent spontaneous abortion

          -  Clinical diagnosis of Antiphospholipid syndrome

        Exclusion Criteria:

          -  Other autoimmune diseases

          -  Hematopoietic system diseases

          -  Cardiovascular system diseases

          -  Gastrointestinal system diseases

          -  Urinary system diseases

          -  Nervous system or mental diseases

          -  Have taken other drugs recently
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shihua Bao</last_name>
    <phone>86-021-20261599</phone>
    <email>baoshihua@tongji.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai First Maternity and Infant Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shihua Bao</last_name>
      <phone>86-021-20261599</phone>
      <email>baoshihua@tongji.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>November 1, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2018</study_first_posted>
  <last_update_submitted>November 7, 2018</last_update_submitted>
  <last_update_submitted_qc>November 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai First Maternity and Infant Hospital</investigator_affiliation>
    <investigator_full_name>Shihua Bao</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abortion, Spontaneous</mesh_term>
    <mesh_term>Fetal Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

